ST
Sunil Thakran
About Sunil Thakran
Sunil Thakran has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Crea8 Solutions Llp and Makesson Healthcure Private Limited. Formerly with 2 companies, such as Waymon Global Private Limited and Citicargo India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Crea8 Solutions Llp
AAR-2957
|
Designated Partner | 12 Dec 2019 | 2019 | Active |
Makesson Healthcure Private Limited
U24304MH2017PTC291630
|
Director | 23 Feb 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Waymon Global Private Limited
U15400DL2022PTC399171
|
Director | 27 May 2022 | 2022 | Active |
Citicargo India Private Limited
U63030DL2022PTC398964
|
Director | 25 May 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Thakran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Thakran
Sunil Thakran has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Crea8 Solutions Llp and Makesson Healthcure Private Limited. Formerly with 2 companies, such as Waymon Global Private Limited and Citicargo India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Sunil Thakran is associated with 2 companies as Designated Partner and Director.
Sunil Thakran has expertise in General Business, Healthcare.
Sunil Thakran has 9 years in corporate governance.